This finding not only identifies IPA as a promising candidate for the development of novel, safe, and effective therapies against S. aureus-induced mastitis but also provides new insights into targeting the gut metabolite-AhR axis to regulate mammary gland inflammation and barrier function. This evidence concerns the gene AHR and mastitis.